Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.

Clinical endocrinology - 1 Apr 2000

Globerman H, Zauberman Y, Makarov T, Beamer B A, Yen C J, Shuldiner A R, Harel C, Karnieli E

Abstract excerpt

OBJECTIVES: To test the hypothesis that the triad of hyperandrogenism, insulin resistance and acanthosis nigricans (HAIRAN syndrome) in the presence of obesity, also known as type C insulin resistance, is caused by mutations in the gene for peroxisome proliferator activated receptor gamma (PPARgamma), a receptor for the thiazolidinedione drugs that enhance sensitivity to insulin. To investigate possible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acanthosis Nigricans
Share to Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose Clamp Technique

Share to Hyperandrogenism

Share to Insulin Resistance

Share to Polymorphism, Single-Stranded Conformational

Share to Protein Isoforms

Share to Receptors, Cytoplasmic and Nuclear

Source

Identifiers

PMID: 10762291
DOI: 10.1046/j.1365-2265.2000.00950.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.PMID 10762291Read ↗

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.Semantic proximity Read ↗

Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance).Semantic proximity Read ↗

Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics.Semantic proximity Read ↗

PPARγ and metabolism: insights from the study of human genetic variantsSemantic proximity Read ↗

The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.Semantic proximity Read ↗

Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.Semantic proximity Read ↗

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.Semantic proximity Read ↗

A genetic mutation in PPAR gamma is associated with enhanced fat cell differentiation: implications for human obesity.Semantic proximity Read ↗

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.Semantic proximity Read ↗

Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes.Semantic proximity Read ↗

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.Semantic proximity Read ↗

Functional implications of genetic variation in human PPARgamma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.